Novo Nordisk Faces Setback in Netherlands Over Wegovy Insurance Coverage

Loading...Loading...The famed Danish drug maker Novo Nordisk A/S NVO expressed disappointment on Wednesday following a recommendation by the Dutch Health Care Institute advising the Netherlands government against including the company’s popular weight-loss drug, Wegovy, in the basic insurance coverage.The institute’s recommendation, delivered on Tuesday, cited insufficient clarity on whether Wegovy’s health benefits justify its costs.Related: Bernie Sanders Targets High Prices of Ozempic and Wegovy In US.Al ...